Prostaglandin analogs are first-line glaucoma drops for many Encino and San Fernando Valley patients. A study presented at Academy 2026 asks whether long-term use thins the central cornea enough to make everyday pressure readings look safer than they are.
How the study was done
Daniel Epshtein, OD, FAAO, and colleagues followed patients with glaucoma, ocular hypertension, or glaucoma suspicion at the Albuquerque VA Medical Center. Central corneal thickness was measured with the same ultrasound pachymeter at baseline and about three years later. At visits they compared Goldmann-correlated intraocular pressure with corneal-compensated pressure, which tries to account for corneal biomechanics.
What changed
- 67 eyes on prostaglandin analogs were compared with 61 untreated eyes.
- Average central corneal thinning was 11.7 µm in treated eyes versus 3.4 µm in untreated eyes; one treated cornea thinned by 35 µm.
- Treated eyes showed lower corneal hysteresis and corneal resistance factor.
- Among “super-thinners” (≥20 µm loss), treated eyes showed about a 3.3 mm Hg gap between Goldmann-correlated and corneal-compensated pressure, versus 1.4 mm Hg in untreated super-thinners.
- Eyes that later needed treatment intensification had more thinning even when Goldmann pressures looked similar (about 15.8 vs 16 mm Hg).
- Super-thinners lost visual field faster (−0.32 dB/year) than non-super-thinners (−0.18 dB/year).
What “corneal-compensated” means in plain language
Standard Goldmann-style readings assume a somewhat typical cornea. When chronic drops change thickness and stiffness, that assumption drifts. Corneal-compensated estimates try to factor biomechanics back in. Neither number replaces optic-nerve imaging and fields, but a growing gap between them is a clue to remeasure thickness and rethink whether pressure is truly controlled.
Clinic takeaways
Epshtein argued that clinics should recheck central corneal thickness in long-term prostaglandin users, which is not routine today. Underestimated pressure can create a false sense that the optic nerve is protected.
- Do not stop prescribed drops because of this study.
- Ask whether your thickness has been remeasured if you have used a prostaglandin for years.
- Bring prior pachymetry and field printouts when you change offices.
Khanna Vision Institute monitors glaucoma with pressure, nerve imaging, and fields—not a single number. For cataract-related inflammation questions that often arise in the same age group, see bettervisionatanyage.com.
Source: Corneal thinning induced by prostaglandin use may lead to IOP underestimation (Healio Optometry (Academy 2026 presentation), 10/01/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.